您好,欢迎访问河南省农业科学院 机构知识库!

Nanovaccine Confers Dual Protection Against Influenza A Virus And Porcine Circovirus Type 2

文献类型: 外文期刊

作者: Ding, Peiyang 1 ; Jin, Qianyue 1 ; Chen, Xinxin 1 ; Yang, Suzhen 1 ; Guo, Junqing 1 ; Xing, Guangxu 1 ; Deng, Ruiguang 1 ;

作者机构: 1.Henan Acad Agr Sci, Henan Prov Key Lab Anim Immunol, Zhengzhou 450002, Henan, Peoples R China

2.Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou 450002, Henan, Peoples R China

3.Zhengzhou Univ, Sch Life Sci, Zhengzhou 450001, Henan, Peoples R China

4.Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China

关键词: influenza A virus; porcine circovirus type 2; M2e; nanovaccine; virus-like particles; bivalent vaccine

期刊名称:INTERNATIONAL JOURNAL OF NANOMEDICINE ( 影响因子:6.4; 五年影响因子:6.761 )

ISSN: 1178-2013

年卷期: 2019 年 14 卷

页码:

收录情况: SCI

摘要: Background: The influenza A virus (IAV) is known for its high variability and poses a huge threat to the health of humans and animals. Pigs play a central role in the cross-species reassortment of IAV. Ectodomain of matrix protein 2 (M2e) is the most conserved protective antigen in IAV and can be used to develop nanovaccines through nanoparticles displaying to increase its immunogenicity. However, the high immunogenicity of nanoparticles can cause the risk of off-target immune response, and excess unwanted antibodies may interfere with the protective efficacy of M2e-specific antibodies. Therefore, it is necessary to select reasonable nanoparticles to make full use of antibodies against nanoparticles while increasing the level of M2e-specific antibodies. Porcine circovirus type 2 (PCV2) is the most susceptible virus in pigs and can promote IAV infection. It is meaningful to develop a vaccine that can simultaneously control swine influenza virus (SIV) and PCV2. Methods: In the present study, M2e of different copy numbers were inserted into the capsid (Cap) protein of PCV2 and expressed in Escherichia coli to form self-assembled chimeric virus-like particles (VLPs) nanovaccine. BALB/c mice and pigs were immunized with these nanovaccines to explore optimal anti-IAV and anti-PCV2 immunity. Results: Cap is capable of carrying at least 81 amino acid residues (three copies of M2e) at its C-terminal without impairing VLPs formation. Cap-3M2e VLPs induced the highest levels of M2e-specific immune responses, conferring protection against lethal challenge of IAVs from different species and induced specific immune responses consistent with PCV2 commercial vaccines in mice. In addition, Cap-3M2e VLPs induced high levels of M2e-specific antibodies and PCV2-specific neutralizing antibodies in pigs. Conclusion: Cap-3M2e VLP is an economical and promising bivalent nanovaccine, which provides dual protection against IAV and PCV2.

  • 相关文献
作者其他论文 更多>>